# A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour

> **NCT06383871** · PHASE1 · RECRUITING · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 233 (estimated)

## Conditions studied

- Advanced Malignant Tumour

## Interventions

- **DRUG:** HRS-7058 capsule/ HRS-7058 tablet

## Key facts

- **NCT ID:** NCT06383871
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-06
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 233 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06383871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06383871, "A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT06383871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*